共 76 条
[1]
Duschinsky R(1957)The synthesis of 5-fluoropyrimidines J Am Chem Soc Anticancer 79 4559-60
[2]
Pleven E(1985)Long-term ambulatory continuous iv infusion of 5-FU for the treatment of advanced adenocarcinomas Cancer Treat Rep 69 13-15
[3]
Heidelberger C(1988)Continuous 5-fluorouracil infusion in advanced gastric carcinoma Am J Clin Oncol 11 461-4
[4]
Caballero GA(1985)Long-term ambulatory treatment of metastatic colorectal adenocarcinoma by continuous intravenous infusion of 5-fluorouracil J Surg Oncol 30 60-5
[5]
Ausman RK(1989)A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study J Clin Oncol 7 425-32
[6]
Quebbeman EJ(1996)Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548-57
[7]
Moynihan T(1996)Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats Cancer Res 56 2602-6
[8]
Hansen R(1987)Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts Jpn J Cancer Res 78 748-55
[9]
Anderson T(1993)Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats Cancer Res 53 4004-9
[10]
Quebbeman E(1999)Clinical implications of dihydropyrimidine dehydrogenase Oncology 13 17-21